 
                            
                             
              RestorixHealth, a national leader in comprehensive wound care management, today announced the acquisition of CūtisCare, a premier provider of multi-place hyperbaric medicine and hospital-based services. The strategic partnership expands RestorixHealth’s capabilities, enhancing its ability to support hospital partners and healthcare systems with advanced wound management and hyperbaric solutions.
The newly combined organization will integrate CūtisCare’s specialized hyperbaric medicine expertise with RestorixHealth’s proven operational, clinical, and financial strengths. This collaboration will enable RestorixHealth to provide a full spectrum of hyperbaric medicine services — including both multi-place and mono-place systems — to better meet the diverse needs of hospital partners across the United States.
In addition, through collaborations with leading research institutions, RestorixHealth will continue to invest in validated clinical protocols and evidence-based practices, reinforcing its commitment to safer and more effective patient care.
“Integrating CūtisCare and RestorixHealth’s hospital-based services positions us as the leading solution for partners of all sizes across all communities,” said Ben Dunford, CEO of RestorixHealth. “Our expertise now spans from rural hospitals to large healthcare systems and teaching hospitals. We are excited to grow with each of our centers and hospital partners, expanding our reach to ensure more patients receive the care they need for hard-to-heal wounds.”
The transaction excludes CūtisCare’s RegenQuest division, which focuses on office-based wound healing and hyperbaric programs and will continue operating independently.
“This arrangement brings together unmatched leadership and clinical expertise,” said Dr. William Tettelbach, Chief Medical Officer of RestorixHealth. “It empowers our healthcare partners and frontline providers to deliver safer, more effective, evidence-based care that enhances healing outcomes and helps prevent amputations.”
By partnering with CūtisCare’s network of academic medical centers, hospitals, and health systems — including UC San Diego Health, UCLA Medical Center, and Yale New Haven Health — RestorixHealth will now serve approximately 300 partners across 41 states.
This acquisition follows RestorixHealth’s April 2024 strategic collaboration with Accurate Healthcare, which created an integrated service provider to support wound care in the skilled nursing industry.
Together, RestorixHealth and CūtisCare are redefining the future of hospital-based wound management and hyperbaric medicine, united by a shared mission to improve healing and enhance patient outcomes nationwide.
 
        Subscribe To Our Newsletter & Stay Updated